Tequin

Lea en español

TequinTequin, one of the brand names for the pharmaceutical product Gatifloxacin, was introduced to the U.S. market by Bristol-Myers Squibb in 1999. The drug, an antibiotic, was prescribed primarily for the treatment of respiratory tract infections.

In 2006, a report in the New England Journal of Medicine alleged that Tequin had been found to put users at an elevated risk for dysglycemia, a blood sugar metabolism disorder that may manifest as either hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar). Initially, Bristol-Myers Squibb notified health care providers that product warnings would be enhanced. However, the company subsequently opted to terminate the manufacture of Tequin. The product is now available only as treatment for eye conditions, in the form of an eye drop.

If you experienced side effects after being prescribed Tequin, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Avoiding Probate

I often am asked by clients how they can avoid probate. In some situations, it is appropriate to tak…

12 Jul 2019, Friday

What is the Hatch Act and How Did Kellyanne Conway Violate It?

Office of Special Counsel Calls White House Counselor a “Repeat Offender” and Calls for…

25 Jun 2019, Tuesday

TEVA Pharmaceutical Settles Opioid Lawsuit Before Trial

Israeli Drug Company Agrees to Pay $85 Million A second major pharmaceutical company has decided to…

28 May 2019, Tuesday